Central Trust Company’s LeMaitre Vascular LMAT Stock Holding History

Central Trust Company’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$672	Sell	7 -15	-68%	-$1.54K	﹤0.01%	1519
2026 Q1	$2.4K	Buy	22 +15	+214%	+$1.43K	﹤0.01%	1350
2025 Q4	$568	Buy	+7	New	+$603	﹤0.01%	1431
2024 Q1	–	Sell	-56	Closed	-$3.18K	–	1399
2023 Q4	$3.18K	Hold	56	–	–	﹤0.01%	1227
2023 Q3	$3.05K	Hold	56	–	–	﹤0.01%	1213
2023 Q2	$3.77K	Hold	56	–	–	﹤0.01%	1124
2023 Q1	$2.88K	Hold	56	–	–	﹤0.01%	1163
2022 Q4	$2.58K	Hold	56	–	–	﹤0.01%	1137
2022 Q3	$3K	Hold	56	–	–	﹤0.01%	1161
2022 Q2	$3K	Hold	56	–	–	﹤0.01%	1171
2022 Q1	$3K	Buy	+56	New	+$2.51K	﹤0.01%	1210

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Central Trust Company's LMAT Position: Q2 2026 in Review

Central Trust Company reduced its LeMaitre Vascular (LMAT) stake by 68% in Q2 2026, selling an estimated $1.54K and leaving 7 shares worth $672. The position accounts for ﹤0.01% of the portfolio, ranked #1519.

Central Trust Company first reported a position in LMAT in Q1 2022 and has held it in 11 quarters since. The position peaked at $3.77K in Q2 2023. 327 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

Central Trust Company held 7 shares of LeMaitre Vascular worth $672 as of Q2 2026.
Central Trust Company sold 15 LeMaitre Vascular shares in Q2 2026, an estimated $1.54K.
LeMaitre Vascular made up ﹤0.01% of Central Trust Company's portfolio in Q2 2026, its #1519 holding.
Central Trust Company first reported a position in LeMaitre Vascular in Q1 2022 and has held it in 11 quarters since.
Central Trust Company's LeMaitre Vascular position peaked at $3.77K in Q2 2023.
327 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Central Trust Company's 13F filing for Q2 2026, filed 31 Jul 2026.